Valuein

Overview

BECTON DICKINSON & CO

BDXNYSEHealth CareSurgical & Medical Instruments & ApparatusCIK 0000010795S&P 500

Latest 10-K: FY2025, filed Nov 25, 2025 · Open the 10-K (Inline XBRL) ↗

Revenue
$21.84B
8.2%YoYup from FY2024
TotalRevenue
Gross profit
$9.93B
8.8%YoYup from FY2024
GrossProfit
Operating income
$2.58B
7.6%YoYup from FY2024
OperatingIncome
Net income
$1.68B
1.6%YoYdown from FY2024
NetIncome
Diluted EPS
$5.82
0.7%YoYdown from FY2024
EPSDiluted
Diluted shares
288.5M
0.9%YoYdown from FY2024
WeightedAvgSharesDiluted

At a glance

Growth

  • BECTON DICKINSON & CO reported revenue of $21.84B for fiscal 2025, up 8.2% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 2 of the last 5 fiscal years.

Profitability

  • Operating margin was 11.8% and net margin was 7.7%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.

Per share

  • Diluted EPS was $5.82, down 0.7% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 24, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: S&P 500 median change. Line under a label: how many S&P 500 companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$21.84B8.2%up
S&P 500 6.4%
$20.18B4.2%up
S&P 500 4.5%
$19.37B2.7%up
S&P 500 4.8%
$18.87B1.4%down
S&P 500 10.3%
$19.13B19.0%up
S&P 500 13.8%
3.4%
S&P 500 6.6%
Gross Profit
Median of 315 / 498
$9.93B8.8%up
S&P 500 6.8%
$9.13B11.7%up
S&P 500 5.5%
$8.17B3.6%down
S&P 500 5.2%
$8.48B1.8%down
S&P 500 8.3%
$8.63B13.9%up
S&P 500 15.7%
3.6%
S&P 500 6.2%
Operating Income
Median of 373 / 498
$2.58B7.6%up
S&P 500 7.3%
$2.40B13.5%up
S&P 500 7.4%
$2.11B7.5%down
S&P 500 4.9%
$2.28B1.4%up
S&P 500 7.5%
$2.25B146.7%up
S&P 500 23.5%
3.5%
S&P 500 7.2%
Net Income
$1.68B1.6%down
S&P 500 4.8%
$1.71B14.9%up
S&P 500 5.7%
$1.48B16.6%down
S&P 500 1.9%
$1.78B15.0%down
S&P 500 1.3%
$2.09B139.4%up
S&P 500 33.9%
-5.4%
S&P 500 4.1%
EPS (Diluted)
$5.820.7%down
S&P 500 6.2%
$5.8618.6%up
S&P 500 7.9%
$4.9416.0%down
S&P 500 1.9%
$5.8814.2%down
S&P 500 1.5%
$6.85152.8%up
S&P 500 34.8%
-4.0%
S&P 500 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: S&P 500 median change. Line under a label: how many S&P 500 companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$55.33B3.4%down
S&P 500 5.6%
$57.29B8.5%up
S&P 500 3.4%
$52.78B0.3%down
S&P 500 4.1%
$52.93B1.7%down
S&P 500 2.2%
$53.87B0.3%down
S&P 500 6.7%
0.7%
S&P 500 4.7%
Total Liabilities
Median of 357 / 498
—
—
—
—
—
—
S&P 500 4.4%
Stockholders' Equity
$25.39B1.9%down
S&P 500 6.8%
$25.89B0.4%up
S&P 500 5.4%
$25.80B2.0%up
S&P 500 7.3%
$25.28B6.8%up
S&P 500 2.5%
$23.68B0.4%down
S&P 500 9.0%
1.8%
S&P 500 6.1%
Cash & Equivalents
$0.64B62.7%down
S&P 500 5.2%
$1.72B21.3%up
S&P 500 1.9%
$1.42B40.8%up
S&P 500 6.7%
$1.01B55.9%down
S&P 500 -8.6%
$2.28B19.2%down
S&P 500 -2.9%
-27.2%
S&P 500 2.0%
Total Debt
Median of 393 / 498
$19.18B†4.6%down
S&P 500 2.3%
$20.11B†26.6%up
S&P 500 0.1%
$15.88B†1.2%down
S&P 500 0.1%
$16.07B†8.8%down
S&P 500 0.1%
$17.61B†1.8%down
S&P 500 0.0%
2.2%
S&P 500 3.7%

† Sum of short-term and long-term debt; the company files no total-debt line.

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: S&P 500 median change. Line under a label: how many S&P 500 companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$3.43B10.8%down
S&P 500 6.3%
$3.84B28.6%up
S&P 500 4.8%
$2.99B21.0%up
S&P 500 9.9%
$2.47B46.8%down
S&P 500 -0.7%
$4.65B31.3%up
S&P 500 10.7%
-7.3%
S&P 500 7.0%
Capital Expenditures
$0.76B4.8%up
S&P 500 5.4%
$0.72B17.0%down
S&P 500 2.8%
$0.87B10.2%down
S&P 500 11.3%
$0.97B18.5%down
S&P 500 14.0%
$1.19B55.3%up
S&P 500 8.1%
-10.7%
S&P 500 9.0%
Free Cash Flow
Median of 378 / 498
$2.67B14.4%down
S&P 500 7.3%
$3.12B47.4%up
S&P 500 6.1%
$2.12B41.3%up
S&P 500 8.8%
$1.50B56.6%down
S&P 500 -11.3%
$3.45B24.7%up
S&P 500 10.2%
-6.2%
S&P 500 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

S&P 500 median = median of the companies in the index on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-20. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

3.1%

Wall Street

on net earnings

FY2024 2.4%

4.9%

Value investor

on free cash flow

FY2024 4.4%

Gap +1.8 pts: Value-investor figure 1.8 points higher

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 32.2×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on BDX yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on BDX and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 24, 2026. Canonical address: https://valuein.biz/data/BDX

APA-style text
Valuein. (2026, October 24). BECTON DICKINSON & CO (BDX) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/BDX
BibTeX
@misc{valuein_bdx_2026,
  author = {{Valuein}},
  title = {BECTON DICKINSON \& CO (BDX) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/BDX}},
  note = {Data as of 2026-10-24; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Nov 25, 2025 · accession 0000010795-25-000099

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing